Abstract
A method is described for the separate quantitation of fluorescein and fluorescein glucuronide in the vitreous by differential spectrofluorometry. An ocular fluorometer was equppied with monochromatic laser excitation at two rapidly interchangeable wavelengths. The data analysis accounts for absorption of light in the cornea, lens, and extrinsic ocular fluorophores. Examination of seven patients with insulin-dependent diabetes and different degrees of diabetic retinopathy demonstrated that both fluorescein and fluorescein glucuronide enter the eye through the blood-retina barrier. The mean ratio between the permeabilities of fluorescein glucuronide and fluorescein was 0.9 (range, 0.3–1.9). Thus, differences in the molecular size and lipid solubility of the two substances appear to be of little or no importance for their inward penetration of the barrier. No association was found between the relative permeability and the degree of retinopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American National Standard Institute (1986) ANSI Z-136.1. American national standard for the safe use of lasers. Laser Institute of America, Toledo
Best JA van, Tjin A, Tsoi EWSJ, Boot JP, Oosterhuis JA (1985) In vivo assessment of lens transmission for blue-green light by autofluorescence measurement. Ophthalmic Res 17:90–95
Blair NP, Zeimer RC, Rusin MM, Cunha-Vaz JG (1983) Outward transport of fluorescein from the vitreous in normal human subjects. Arch Ophthalmol 101:1117–1121
Boettner EA, Wolter JR (1962) Transmission of the ocular media. Invest Ophthalmol Vis Sci 1:776–783
Brubaker RF (1982) The flow of aqueous humor in the human eye. Trans Am Ophthalmol Soc 80:391–474
Dalgaard P, Larsen M (1990) Fitting numerical solutions of differential equations to experimental data: a case study and some general remarks. Biometrics 46:1097–1109
Dalgaard P, Barker VA, Lund-Andersen H (1989) Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci 30:1522–1526
Grotte D, Mattox V, Brubaker R (1985) Fluorescent, physiological and pharmacokinetic properties of fluorescein glucuronide. Exp Eye Res 40:23–33
Jacobs R, Krohn DL (1981) Fluorescence intensity profile of human lens sections. Invest Ophthalmol Vis Sci 20:117–120
Kitano S, Nagataki S (1986) Transport of fluorescein monoglucuronide out of the vitreous. Invest Ophthalmol Vis Sci 27:998–1001
Larsen M, Johansson LB-Å (1989) Time-resolved fluorescence properties of fluorescein and fluorescein monoglucuronide. Exp Eye Res 48:477–485
Larsen M, Lund-Andersen H (1989) Fluorescein and fluorescein glucuronide in vitreous: fluorescence and binding properties in vitro. Acta Ophthalmol (Copenh) 67:137–140
Larsen M, Lund-Andersen H (1990) Lens fluorometry: light-attenuation effects and estimation of total lens transmittance. Graefe's Arch Clin Exp Ophthalmol (1991) 229:363–370
Larsen M, Dalgaard P, Lund-Andersen H (1987) Differential spectrofluorophotometry in the human vitreous body. In: Non-invasive assessment of the visual system. Technical digest. Optical Society of America, Washington, pp 144–147
Larsen M, Loft S, Hommel E, Lund-Andersen H (1988) Fluorescein and fluorescein glucuronide in plasma after intravenous injection of fluorescein. Acta Ophthalmol (Copenh) 66:427–432
Larsen M, Dalgaard P, Lund-Andersen H (1990) Determination of spatial coordinates in vitreous fluorometry. Graefe's Arch Clin Exp. Ophthalmol (1991) 229:358–362
Lund-Andersen H, Krogsaa B, Cour M la, Larsen J (1985) Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci 26:698–710
Lund-Andersen H, Larsen M, Dalgaard P, Olsen W (1987) Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patients. Graefe's Arch Clin Exp Ophthalmol 225:173–176
Lund-Andersen H, Larsen M, Larsen H-W, Dalgaard P, Hommel E, Parving HH (1989) Vitreous fluorophotometry as a possible predictor of the development of diabetic retinopathy: a pilot study. In: Cunha-Vaz JG, Leite E (eds) Ocular fluorometry and the future. Kugler & Ghedini, Amsterdam, pp 165–167
Matsunaga I, Nagataki S, Tamura Z (1984) Synthesis of fluorescein monoglucuronide. Chem Pharm Bull (Tokyo) 32:2832–2835
McLaren JW, Brubaker RF (1986) Measurement of fluorescein and fluorescein monoglucuronide in the living human eye. Invest Ophthalmol Vis Sci 27:966–974
McLaren JW, Brubaker RF (1988) A scanning ocular spectrofluorophotometer. Invest Ophthalmol Vis Sci 29:1285–1293
Schichi H, Nebert DW (1980) Drug metabolism in ocular tissues. In: Gram TE (ed) Extrahepatic metabolism of drugs and other foreign compounds. Spectrum, Jamaica, New York
Zeimer RC, Lim HK, Ogura Y (1987) Evaluation of an objective method for the “in vivo” measurement of changes in light transmittance of the human crystalline lens. Exp Eye Res 45:969–976
Author information
Authors and Affiliations
Additional information
This study was supported by Danish Medical Research Council grant 12-8301
Offprint requests to: M. Larsen
Rights and permissions
About this article
Cite this article
Larsen, M., Dalgaard, P. & Lund-Andersen, H. Differential spectrofluorometry in the human vitreous: blood-retina barrier permeability to fluorescein and fluorescein glucuronide. Graefe's Arch Clin Exp Ophthalmol 229, 350–357 (1991). https://doi.org/10.1007/BF00170694
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00170694